Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
The Journal of Surgical Research
|
August 28, 2016
High levels of sphingolipids in human breast cancer
Masayuki Nagahashi, Junko Tsuchida, Kazuki Moro, et al.
Anticancer Research
|
January 31, 2025
Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging Projection System in Breast Cancer Patients, Including Those Following Neoadjuvant Chemotherapy
Aoi Oshiro, Masayuki Nagahashi, Yusa Togashi, et al.
Oncotarget
|
May 8, 2018
Ceramide species are elevated in human breast cancer and are associated with less aggressiveness
Kazuki Moro, Tsutomu Kawaguchi, Junko Tsuchida, et al.
Annals of Surgical Oncology
|
November 22, 2025
TRIM37 Expression is Associated with Immune Suppression Poor Response to Neoadjuvant Chemotherapy and Worse Survival in ER-Positive/HER2-Negative Breast Cancer
Junko Tsuchida, Rongrong Wu, Masayuki Nagahashi, et al.
The Journal of Surgical Research
|
August 19, 2020
Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer
Junko Tsuchida, Masayuki Nagahashi, Masato Nakajima, et al.
International Journal of Clinical Oncology
|
April 28, 2025
Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan
Yusa Togashi, Masayuki Nagahashi, Aoi Oshiro, et al.
The Journal of Surgical Research
|
November 23, 2018
Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression
Kizuki Yuza, Masato Nakajima, Masayuki Nagahashi, et al.
Surgery Today
|
October 31, 2015
DNA damage response and sphingolipid signaling in liver diseases
Masayuki Nagahashi, Yasunobu Matsuda, Kazuki Moro, et al.
International Journal of Clinical Oncology
|
September 15, 2024
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer
Ayumu Mitsuyoshi, Masayuki Nagahashi, Haruka Kanaoka, et al.
Case Reports in Surgery
|
April 10, 2014
A case of perforated sigmoid diverticulitis in which gram staining of ascitic fluid was useful for diagnosis
Junko Tsuchida, Shouhei Fujita, Fumihiro Kawano, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
The Journal of Surgical Research
|
August 28, 2016
High levels of sphingolipids in human breast cancer
Masayuki Nagahashi, Junko Tsuchida, Kazuki Moro, et al.
Anticancer Research
|
January 31, 2025
Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging Projection System in Breast Cancer Patients, Including Those Following Neoadjuvant Chemotherapy
Aoi Oshiro, Masayuki Nagahashi, Yusa Togashi, et al.
Oncotarget
|
May 8, 2018
Ceramide species are elevated in human breast cancer and are associated with less aggressiveness
Kazuki Moro, Tsutomu Kawaguchi, Junko Tsuchida, et al.
Annals of Surgical Oncology
|
November 22, 2025
TRIM37 Expression is Associated with Immune Suppression Poor Response to Neoadjuvant Chemotherapy and Worse Survival in ER-Positive/HER2-Negative Breast Cancer
Junko Tsuchida, Rongrong Wu, Masayuki Nagahashi, et al.
The Journal of Surgical Research
|
August 19, 2020
Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer
Junko Tsuchida, Masayuki Nagahashi, Masato Nakajima, et al.
International Journal of Clinical Oncology
|
April 28, 2025
Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan
Yusa Togashi, Masayuki Nagahashi, Aoi Oshiro, et al.
The Journal of Surgical Research
|
November 23, 2018
Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression
Kizuki Yuza, Masato Nakajima, Masayuki Nagahashi, et al.
Surgery Today
|
October 31, 2015
DNA damage response and sphingolipid signaling in liver diseases
Masayuki Nagahashi, Yasunobu Matsuda, Kazuki Moro, et al.
International Journal of Clinical Oncology
|
September 15, 2024
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer
Ayumu Mitsuyoshi, Masayuki Nagahashi, Haruka Kanaoka, et al.
Case Reports in Surgery
|
April 10, 2014
A case of perforated sigmoid diverticulitis in which gram staining of ascitic fluid was useful for diagnosis
Junko Tsuchida, Shouhei Fujita, Fumihiro Kawano, et al.
Page
of 5